Boston Scientific Sues Stryker Over Back Pain Treatment Patent

Boston Scientific Corp. filed a federal lawsuit seeking a court’s judgment that Stryker Corp.'s release of a lower back pain treatment would infringe its patent for a similar treatment.

Boston Scientific’s US Patent No. 12,303,166 relates to methods for ablating a basivertebral nerve in a patient’s vertebra, according to the complaint Boston Scientific and its subsidiary Relievant Medsystems Inc. filed Wednesday in the US District Court for the District of New Jersey.

Stryker’s recently FDA-cleared OptaBlate BVN product has the same intended use and will induce infringement of the ‘166 patent when launched, the complaint said. Stryker instructs physicians to ...